Global Antacids Market - Segmented by Drug Class, Formulation Type, Distribution Channel and Geography - Growth, Trends, and Forecast (2022 - 2030)
Antacids Market Overview
The Antacids Market is expected to grow, at a CAGR of approximately 4.3% during the forecast period. Some of the key drug categories existing in the antacid market include Proton pump inhibitor, H2 antagonist and acid neutralizers. Out of the three drug categories, proton pump inhibitors segment is expected to hold the largest share in global revenue over the forecast period.
Growing Geriatric Population Suffering from GERD Induce a Surge in the Antacids Market
People with ages of 60 years or higher is rising at a rate of approximately 3% every year and 65% of geriatric population have to deal with acid reflux, and this is one of the major factors boosting the antacid market globally. According to World Health Organization 2017, more than USD 10 billion is spent globally every year on antacids. As per World Gastroenterology Organization, the prevalence rate of GERD is growing globally and the prevalence reached approximately 2.5% - 6.6% in South East Asia and almost 13.8% - 25.8% in North America. Along with this other factors such as poor lifestyle choices leading to higher incidences of acidity and side effects of drugs like non-steroidal anti-inflammatory drugs will also contribute to the growth of the antacids market during the forecast period.
Side Effects Related to Antacids and Drug Interactions to Impede the growth of Antacids Market
Antacids often lead to milk alkali syndrome and rebound acidity due to dose dependence. Antacids which consist of aluminum hydroxide may cause constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. Antacids that contain magnesium have a laxative result which might lead to diarrhea, and in patients suffering from kidney failure, the higher magnesium deposits can create further health complications.
Availability of OTC antacids and their common usage in most of the population using other medications can lead to drug interactions and severe side effects. For instance, antacids when taken with acidic drugs like digoxin, chlorpromazine, etc. lead to the absorption of the drugs, due to which the concentration of the drugs in the blood is very low, which in turn reduces the efficacy of the drugs. Other factors which will affect the market growth include lack of awareness about acidity symptoms and growing number of alternatives in the market for antacids.
Europe to Dominate the Antacids Market
Europe accounted for the largest share in the antacids market in 2017 due to factors such as increasing incidence of gastro esophageal reflux diseases and growing geriatric population. The region being home to some of the key players is also stoking growth of this regional market. Asia Pacific stood as the second-leading market for antacids in 2016. The region is anticipated to clock a high and constant CAGR from 2018 - 2023 to account for the second-leading revenue through this period. China and India are key domestic markets in the region due to improvement of healthcare services.
Key Developments in the Antacids Market:
• Jun 2018: German chemical and pharmaceutical giant Bayer completed the $63 billion mega-deal acquiring the US based biotech major Monsanto.
• Jan 2017: FDA approved Teva's generic version of AstraZeneca's Nexium. The US Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug.
• Sep 2017: Lannett Co. Inc. received Food and Drug Administration approval to market a generic version of delayed-release Nexium in 20- and 40-milligram dosages
Major Players: ASTRAZENECA,BAYER AG, BOEHRINGER INGELHEIM GMBH, DR. REDDY’S LABORATORIES LTD., GLAXOSMITHKLINE PLC, JOHNSON & JOHNSON, PFIZER INC., PROCTER & GAMBLE, RECKITT BENCKISER GROUP PLC, SANOFI, SUN PHARMACEUTICALS LTD, TAKEDA PHARMACEUTICAL, and VALEANT PHARMACEUTICALS INTERNATIONAL, INC. among others
Reasons to Purchase the Antacids Market Report
• Current and future Antacids Market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimation sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
The Antacids Market is expected to grow, at a CAGR of approximately 4.3% during the forecast period. Some of the key drug categories existing in the antacid market include Proton pump inhibitor, H2 antagonist and acid neutralizers. Out of the three drug categories, proton pump inhibitors segment is expected to hold the largest share in global revenue over the forecast period.
Growing Geriatric Population Suffering from GERD Induce a Surge in the Antacids Market
People with ages of 60 years or higher is rising at a rate of approximately 3% every year and 65% of geriatric population have to deal with acid reflux, and this is one of the major factors boosting the antacid market globally. According to World Health Organization 2017, more than USD 10 billion is spent globally every year on antacids. As per World Gastroenterology Organization, the prevalence rate of GERD is growing globally and the prevalence reached approximately 2.5% - 6.6% in South East Asia and almost 13.8% - 25.8% in North America. Along with this other factors such as poor lifestyle choices leading to higher incidences of acidity and side effects of drugs like non-steroidal anti-inflammatory drugs will also contribute to the growth of the antacids market during the forecast period.
Side Effects Related to Antacids and Drug Interactions to Impede the growth of Antacids Market
Antacids often lead to milk alkali syndrome and rebound acidity due to dose dependence. Antacids which consist of aluminum hydroxide may cause constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. Antacids that contain magnesium have a laxative result which might lead to diarrhea, and in patients suffering from kidney failure, the higher magnesium deposits can create further health complications.
Availability of OTC antacids and their common usage in most of the population using other medications can lead to drug interactions and severe side effects. For instance, antacids when taken with acidic drugs like digoxin, chlorpromazine, etc. lead to the absorption of the drugs, due to which the concentration of the drugs in the blood is very low, which in turn reduces the efficacy of the drugs. Other factors which will affect the market growth include lack of awareness about acidity symptoms and growing number of alternatives in the market for antacids.
Europe to Dominate the Antacids Market
Europe accounted for the largest share in the antacids market in 2017 due to factors such as increasing incidence of gastro esophageal reflux diseases and growing geriatric population. The region being home to some of the key players is also stoking growth of this regional market. Asia Pacific stood as the second-leading market for antacids in 2016. The region is anticipated to clock a high and constant CAGR from 2018 - 2023 to account for the second-leading revenue through this period. China and India are key domestic markets in the region due to improvement of healthcare services.
Key Developments in the Antacids Market:
• Jun 2018: German chemical and pharmaceutical giant Bayer completed the $63 billion mega-deal acquiring the US based biotech major Monsanto.
• Jan 2017: FDA approved Teva's generic version of AstraZeneca's Nexium. The US Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug.
• Sep 2017: Lannett Co. Inc. received Food and Drug Administration approval to market a generic version of delayed-release Nexium in 20- and 40-milligram dosages
Major Players: ASTRAZENECA,BAYER AG, BOEHRINGER INGELHEIM GMBH, DR. REDDY’S LABORATORIES LTD., GLAXOSMITHKLINE PLC, JOHNSON & JOHNSON, PFIZER INC., PROCTER & GAMBLE, RECKITT BENCKISER GROUP PLC, SANOFI, SUN PHARMACEUTICALS LTD, TAKEDA PHARMACEUTICAL, and VALEANT PHARMACEUTICALS INTERNATIONAL, INC. among others
Reasons to Purchase the Antacids Market Report
• Current and future Antacids Market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the market estimation sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
